FR2449450A1 - Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension - Google Patents

Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension

Info

Publication number
FR2449450A1
FR2449450A1 FR8003669A FR8003669A FR2449450A1 FR 2449450 A1 FR2449450 A1 FR 2449450A1 FR 8003669 A FR8003669 A FR 8003669A FR 8003669 A FR8003669 A FR 8003669A FR 2449450 A1 FR2449450 A1 FR 2449450A1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
hypertension
treatment
novel pharmaceutical
salidiuretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8003669A
Other languages
English (en)
Other versions
FR2449450B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2449450A1 publication Critical patent/FR2449450A1/fr
Application granted granted Critical
Publication of FR2449450B1 publication Critical patent/FR2449450B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

L'INVENTION A POUR OBJET DE NOUVELLES COMPOSITIONS PHARMACEUTIQUES. SELON L'INVENTION, CES COMPOSITIONS PHARMACEUTIQUES CONTIENNENT, COMME PRINCIPES ACTIFS: A.LA 6-BENZOYL-3-HYDRAZINO-5,6,7,8-TETRAHYDROPYRIDO 4,3-C PYRIDAZINE; B.UN AGENT SALIDIURETIQUE, ET C.LE 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY) INDOLE. CES COMPOSITIONS PHARMACEUTIQUES PEUVENT ETRE UTILISEES POUR LE TRAITEMENT DE L'HYPERTENSION.
FR8003669A 1979-02-22 1980-02-20 Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension Granted FR2449450A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH178579A CH643457A5 (de) 1979-02-22 1979-02-22 Pharmazeutische praeparate zur behandlung der hypertonie.

Publications (2)

Publication Number Publication Date
FR2449450A1 true FR2449450A1 (fr) 1980-09-19
FR2449450B1 FR2449450B1 (fr) 1983-07-22

Family

ID=4218544

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8003669A Granted FR2449450A1 (fr) 1979-02-22 1980-02-20 Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension

Country Status (20)

Country Link
JP (1) JPS55115823A (fr)
AT (1) AT378915B (fr)
AU (1) AU538599B2 (fr)
BE (1) BE881763A (fr)
CA (1) CA1147657A (fr)
CH (1) CH643457A5 (fr)
DE (1) DE3005029A1 (fr)
FR (1) FR2449450A1 (fr)
GB (1) GB2044101B (fr)
HU (1) HU187271B (fr)
IE (1) IE49073B1 (fr)
IL (1) IL59432A (fr)
IT (1) IT1145433B (fr)
MY (1) MY8500619A (fr)
NL (1) NL8001000A (fr)
NZ (1) NZ192924A (fr)
PH (1) PH17118A (fr)
PT (1) PT70855A (fr)
SE (2) SE8001121L (fr)
ZA (1) ZA801018B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2537434A1 (fr) * 1982-12-09 1984-06-15 Sandoz Sa Composition pharmaceutique d'endralazine sous forme retard

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2255071A1 (fr) * 1973-12-19 1975-07-18 Sandoz Sa

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2255071A1 (fr) * 1973-12-19 1975-07-18 Sandoz Sa

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/78 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2537434A1 (fr) * 1982-12-09 1984-06-15 Sandoz Sa Composition pharmaceutique d'endralazine sous forme retard

Also Published As

Publication number Publication date
CH643457A5 (de) 1984-06-15
ATA95580A (de) 1985-03-15
HU187271B (en) 1985-12-28
NL8001000A (nl) 1980-08-26
BE881763A (fr) 1980-08-18
IL59432A (en) 1984-08-31
GB2044101A (en) 1980-10-15
PT70855A (fr) 1980-03-01
DE3005029C2 (fr) 1987-02-12
IT8047950A0 (it) 1980-02-20
MY8500619A (en) 1985-12-31
GB2044101B (en) 1983-09-07
AU5574280A (en) 1980-08-28
IE800336L (en) 1980-08-22
SE8202357L (en) 1982-04-15
IL59432A0 (en) 1980-05-30
NZ192924A (en) 1984-05-31
JPS55115823A (en) 1980-09-06
AT378915B (de) 1985-10-25
PH17118A (en) 1984-06-01
DE3005029A1 (de) 1980-09-04
IE49073B1 (en) 1985-07-24
FR2449450B1 (fr) 1983-07-22
ZA801018B (en) 1981-09-30
CA1147657A (fr) 1983-06-07
SE8001121L (sv) 1980-08-23
AU538599B2 (en) 1984-08-23
IT1145433B (it) 1986-11-05

Similar Documents

Publication Publication Date Title
BE853086A (fr) Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis
ATE61050T1 (de) Pyridazinamine wirksam gegen viren.
MX9102209A (es) Derivados de acido hidroxamico y n-hidroxiurea novedosos y su uso.
DK155143C (da) Antioestrogent laegemiddel til behandling af benigne og canceroese tilstande i brystet
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate
ES482723A1 (es) Un procedimiento para la obtencion de una composicion de clotrimazol
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
FR2608045B1 (fr) Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome
BE900564A (fr) Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.
IT8019711A0 (it) Composizioni da usarsi come cosmetici e procedimento per lapreparazione dei loro ingredienti attivi.
JPS5218813A (en) Plasters for the relief of cutaneous diseases
FR2453648A1 (fr) Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique
BE884756A (fr) Composition dermatologique pour le traitement des maladies de la peau, accompagnees d'une proliferation cellulaire, telles que le psoriasis
AU530678B2 (en) Phosphono-hydroxy-acetic acid
FR2449450A1 (fr) Nouvelles compositions pharmaceutiques utilisables pour le traitement de l'hypertension
FI861329A (fi) Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
JPS5238507A (en) Detergent composition
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
DE69103773T2 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
SE8704240L (sv) Analgetiska preparat
HUP9903892A2 (hu) Hidroxámsavszármazékok
JPS5318529A (en) Optically active mandelic acid phenylglycinol salt and its preparation
ES481225A1 (es) Procedimiento para la preparacion de un medicamento con efecto antivirico que contiene acido ribonucleico de transferen-cia.
BE899277A (fr) Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation.
GB1353834A (en) Benzenesulphonamides

Legal Events

Date Code Title Description
ST Notification of lapse